A predicted receptor-binding and critical neutralizing domain in S protein of the novel human coronavirus HCoV-EMC
- 31 May 2013
- journal article
- other
- Published by Elsevier BV in Journal of Infection
- Vol. 66 (5), 464-466
- https://doi.org/10.1016/j.jinf.2012.12.003
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Is the discovery of the novel human betacoronavirus 2c EMC/2012 (HCoV-EMC) the beginning of another SARS-like pandemic?Journal of Infection, 2012
- Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi ArabiaNew England Journal of Medicine, 2012
- Emerging Human Coronaviruses — Disease Potential and PreparednessNew England Journal of Medicine, 2012
- SARS veterans tackle coronavirusNature, 2012
- The spike protein of SARS-CoV — a target for vaccine and therapeutic developmentNature Reviews Microbiology, 2009
- Identification and characterization of novel neutralizing epitopes in the receptor-binding domain of SARS-CoV spike protein: Revealing the critical antigenic determinants in inactivated SARS-CoV vaccineVaccine, 2006
- The SWISS-MODEL workspace: a web-based environment for protein structure homology modellingBioinformatics, 2005
- Structure of SARS Coronavirus Spike Receptor-Binding Domain Complexed with ReceptorScience, 2005
- Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccineBiochemical and Biophysical Research Communications, 2004
- Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirusNature, 2003